top of page
Executive Spotlights

Chiesi to Buy Amryt for $1.5 Billion in Rare Disease Expansion

Cary, NC, January 8, 2023 (Bloomberg) -- Chiesi Farmaceutici SpA agreed to buy Amryt Pharma Plc for as much as $1.48 billion to expand its portfolio of medicines that treat rare diseases.

Read full article here.

Recent Posts

See All

Santa Clara, CA, January 17, 2023 (RTTNews) -- Shockwave Medical, Inc. (SWAV) has entered into a definitive agreement to acquire Neovasc Inc. (NVCN). Shockwave will acquire all outstanding Neovasc s

Life Science Headlines
bottom of page